MRNA Jan 2025 90.000 put
| Previous close | 8.80 |
| Open | 9.00 |
| Bid | 8.80 |
| Ask | 10.05 |
| Strike | 90.00 |
| Expiry date | 2025-01-17 |
| Day's range | 9.00 - 9.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 43 |
- Zacks
Moderna (MRNA) Gains But Lags Market: What You Should Know
Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session.
- Motley Fool
3 No-Brainer Growth Stocks to Buy in 2023
In last-year's difficult market, growth stocks were among the first to suffer. Why should we be confident about growth stocks? Moderna (NASDAQ: MRNA) went from zero product revenue prior to the pandemic to about $18 billion annually over the past two years.
- Business Wire
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
FREMONT, Calif., February 03, 2023--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the companies have signed a new agreement to continue using the Personalis NeXT Platform® as part of upcoming clinical studies evaluating mRNA-4157/V940, an investigational personalized cancer vaccine, jointly developed by Moderna and Merck, kn
